A Decade of Research.
A Legacy of Innovation.

A Decade of Research.
A Legacy of Innovation.

Established in 2014, the Wadhwani Research Centre for Bioengineering (WRCB) at IIT Bombay has spent over a decade advancing biosciences and bioengineering research and translating scientific discoveries into healthcare innovations. Building on this strong foundation, the Wadhwani Innovation Centre (WIC) was inaugurated in 2026 to strengthen the focus on technology translation, commercialisation, and real-world deployment. WIC carries forward WRCB’s legacy, accelerating healthcare innovation from research to real-world impact in India and globally.

Wadhwani Research Centre for Bioengineering

The Wadhwani Research Centre for Bioengineering (WRCB) at IIT Bombay has, over the past decade, played a pivotal role in advancing biosciences and bioengineering research.

Established through the philanthropic support of Dr. Romesh Wadhwani, WRCB has enabled the translation of scientific discoveries into impactful innovations addressing critical healthcare challenges. Its efforts have laid the foundation for a strong translational ecosystem at IIT Bombay.

WRCB, IIT Bombay and Wadhwani Foundation signage on the glass wall of the Wadhwani Research Centre for Bioengineering

Startups Supported by WRCB

WRCB has supported a diverse portfolio of startups translating cutting-edge research into real-world healthcare solutions, spanning diagnostics, therapeutics, and medical technologies.

ImmunoACT

ImmunoACT

Est. 2018

Gene-modified CAR-T cell therapies; NexCAR19 is India’s first indigenous CAR-T therapy.

Read more

Read more

Website

MetFlux

MetFlux

Est. 2017

Systems biology and multi-omics modelling for drug discovery and personalised health.

Read more

Read more

Website

Algorithmic Biologics

Algorithmic Biologics

Est. 2021

Algorithm-driven molecular diagnostics; its Tapestry platform makes large-scale PCR and sequencing affordable.

Read more

Read more

Website

Clarity Bio Systems

Clarity Bio Systems

Est. 2020

AI-driven metabolomics combining mass spectrometry and machine learning.

Read more

Read more

Website

ImmunoACT

Est. 2018

Gene-modified CAR-T cell therapies; NexCAR19 is India’s first indigenous CAR-T therapy.

Read more

Website

MetFlux

Est. 2017

Systems biology and multi-omics modelling for drug discovery and personalised health.

Read more

Website

Algorithmic Biologics

Est. 2021

Algorithm-driven molecular diagnostics; its Tapestry platform makes large-scale PCR and sequencing affordable.

Read more

Website

View All Startups →

View All Startups →

Impact at a Glance

117

Projects Completed

1,000+

Publications

150+

Patents Filed

17

Technology Transfers

22

Startups

Impact at a Glance

Impact at a Glance

117

Projects Completed

Projects Completed

1,000+

Publications

Publications

150+

Patents Filed

Patents Filed

17

Technology Transfers

Technology Transfers

22

Startups

Startups

Success stories

From Lab to Impact

WRCB has enabled several innovations to progress from early-stage research to translational and commercial pathways. These success stories highlight the journey of technologies addressing real-world healthcare needs.

News report on India’s indigenous CAR-T cell therapy bringing treatment cost down from Rs 4 crore to Rs 40 lakh

Success story

ImmunoACT: Affordable CAR-T Cell Therapy

Prof. Rahul Purwar · ImmunoACT

Prof. Rahul Purwar’s startup ImmunoACT has brought down the treatment cost of CAR-T cell therapy from INR 4 Cr ($400K) to INR 40 L ($40K). The technology, NexCAR19, was dedicated to the nation by the Honourable President Smt. Droupadi Murmu in April 2024.

Prof. Manoj Gopalkrishnan with the National Startup Awards 2022 certificates

Success story

National Startup Awards 2022

Prof. Manoj Gopalkrishnan & team

Prof. Manoj Gopalkrishnan and his team won the Startup India 2022 award for Best Startup in Life Sciences. It also won the Best Women-led Startup award, making it the only startup to win in both categories.

Prof. Debjani Paul at the licensing of her sickle cell diagnostic technology

Success story

Sickle Cell Diagnostic Technology Licensed

Prof. Debjani Paul

Prof. Debjani Paul licensed her sickle cell diagnostic technology, taking it a step closer to patients who need affordable screening.

Dr. Preethi A. Murugan on stage at E-Summit 2024

Success story

Runner-up at Eureka E-Summit 2024

Dr. Preethi A. Murugan

Dr. Preethi A. Murugan was runner-up in the pan-IIT track at Eureka, E-Summit 2024.

Dr. Uddipta Singh receiving the Gandhian Young Technological Innovation Award

Success story

Gandhian Young Technological Innovation Award

Dr. Uddipta Singh · Prof. Prasanna Gandhi’s lab, Mechanical Engineering

Dr. Uddipta Singh, a PhD scholar with Prof. Prasanna Gandhi (Mechanical Engineering), received the prestigious Gandhian Young Technological Innovation Award for his WRCB-supported work on a novel method for plasma extraction from a blood droplet.

117+ translational projects

117+ translational projects

Portfolio of Innovations

Over the past decade, the Wadhwani Research Centre for Bioengineering (WRCB) at IIT Bombay has supported more than 117 translational research projects across a broad spectrum of technology maturity from early stage ideas and proof-of-concept studies to more advanced experimental validations.

This portfolio represents a curated collection of innovations developed within our ecosystem. Several of these technologies are currently at laboratory or prototype stages, reflecting the early and exploratory nature of academic translational research, with a strong emphasis on addressing unmet clinical and industrial needs.

It highlights the depth and diversity of ongoing innovation, fosters academic–industry engagement, and enables partners to explore opportunities for further development, validation, and translation.

View the portfolio

WRCB Portfolio of Innovations

WRCB Portfolio of Innovations

Microfluidic exosome isolation platform
3D scaffold for cell regeneration in load bearing tissues
POC Glycated Albumin detection device
CBF imaging of small animal stroke models
POC AI enabled early cardiac risk assessment
Blood viscosity based POC diagnostic platform

Diagnostics · Therapeutics · MedTech · Synthetic Biology

Diagnostics · Therapeutics · MedTech · Synthetic Biology

View the portfolio

View the portfolio

View the portfolio

Building a Collaborative Ecosystem

Over the past decade, WRCB has fostered a vibrant ecosystem through strategic partnerships, events, and engagement across academia, industry, and healthcare.

WRCB has organized and participated in a wide range of workshops, conferences, and knowledge-sharing sessions, bringing together researchers, clinicians, and industry leaders to exchange ideas and drive innovation.

01

01

Industry & Academic Collaborations

Strong collaborations with industry and academic institutions have enabled co-development, technology transfer, and advancement of translational research initiatives.

Events & Workshops

industry day
biopharma
himedia
biotherapeutics
biotherapeutics
ankur
showcase
patent
ihf
ihf

02

02

Startup & Ecosystem Engagement

Through active engagement with startups and innovators, WRCB has fostered mentorship, networking, and opportunities for growth within the innovation ecosystem.

Events & Workshops

03

03

CSR & Partner Engagement

WRCB has worked closely with CSR partners and stakeholders to strengthen infrastructure and support impactful translational programs.

Events & Workshops

csr
birac
board
img2024
img2024

Wadhwani Innovation Centre

A Legacy of Innovation. A Future of Impact.

A Legacy of Innovation. A Future of Impact.

Building on a decade of impactful work at WRCB, the vision has now expanded to focus more strongly on translating innovations from the laboratory to market-ready solutions. This next phase was marked by the inauguration of the Wadhwani Innovation Centre (WIC) in 2026, reflecting a strategic shift toward enabling real-world deployment and scale.

As we move forward, we look ahead to achieving new milestones in advancing innovation, strengthening partnerships, and delivering meaningful impact in healthcare.

WRCB

A decade of supporting translational research

WIC

Translating Innovation into Impact

Explore WIC

Explore WIC

WRCB team group photo at the Wadhwani Research Centre for Bioengineering

View all 8 photos

WRCB team group photo at the Wadhwani Research Centre for Bioengineering

View all 8 photos

Dignitaries at the launch of the Wadhwani Superhub at IIT Bombay
Dignitaries at the launch of the Wadhwani Superhub at IIT Bombay
Dignitaries at the launch of the Wadhwani Superhub at IIT Bombay
Dignitaries at the launch of the Wadhwani Superhub at IIT Bombay
Dignitaries at the launch of the Wadhwani Superhub at IIT Bombay
Team at the HiMedia Laboratories and WRCB Bioinnovation Laboratory
Team at the HiMedia Laboratories and WRCB Bioinnovation Laboratory

+6

+6

+5

+5

View all photos

View all photos

View all photos

List of Ongoing Projects

Translational research projects currently being supported at IIT Bombay.

1

1

1

Development of High-Throughput Breast Cancer Patient-derived Tumor Organoids for Anti-Cancer Drug Testing and Personalized Medicine

Development of High-Throughput Breast Cancer Patient-derived Tumor Organoids for Anti-Cancer Drug Testing and Personalized Medicine

Development of High-Throughput Breast Cancer Patient-derived Tumor Organoids for Anti-Cancer Drug Testing and Personalized Medicine

Ongoing

2

2

2

Automated Platform for Design & Manufacture of Semi-Solid Formulations

Automated Platform for Design & Manufacture of Semi-Solid Formulations

Automated Platform for Design & Manufacture of Semi-Solid Formulations

Ongoing

3

3

3

Benchmarking a Human Placenta-on-Chip Platform for Predictive Pregnancy Drug Toxicity Screening

Benchmarking a Human Placenta-on-Chip Platform for Predictive Pregnancy Drug Toxicity Screening

Benchmarking a Human Placenta-on-Chip Platform for Predictive Pregnancy Drug Toxicity Screening

Ongoing

4

4

4

Phytonanogel Shield: Precision Care for Psoriasis Patients

Phytonanogel Shield: Precision Care for Psoriasis Patients

Phytonanogel Shield: Precision Care for Psoriasis Patients

Ongoing

5

5

5

Development of an Indigenous Low-Cost 3D-Printed Flow Cytometer for Resource-Constrained Diagnostics

Development of an Indigenous Low-Cost 3D-Printed Flow Cytometer for Resource-Constrained Diagnostics

Development of an Indigenous Low-Cost 3D-Printed Flow Cytometer for Resource-Constrained Diagnostics

Ongoing

6

6

6

Spectral Fingerprints-Driven Pattern Recognition for Biologic HOS, Aggregates, and Immunogenicity

Spectral Fingerprints-Driven Pattern Recognition for Biologic HOS, Aggregates, and Immunogenicity

Spectral Fingerprints-Driven Pattern Recognition for Biologic HOS, Aggregates, and Immunogenicity

Ongoing

7

7

7

Functional Conducting Hydrogels and GelMA for Biomedical Applications

Functional Conducting Hydrogels and GelMA for Biomedical Applications

Functional Conducting Hydrogels and GelMA for Biomedical Applications

Ongoing

8

8

8

Predicting Breast Cancer Receptor Status and Molecular Subtype Using MRI Images

Predicting Breast Cancer Receptor Status and Molecular Subtype Using MRI Images

Predicting Breast Cancer Receptor Status and Molecular Subtype Using MRI Images

Ongoing

9

9

9

IoT-enabled Artificial Knee Joint Model for Objective Assessment in Orthopaedic Surgical Training

IoT-enabled Artificial Knee Joint Model for Objective Assessment in Orthopaedic Surgical Training

IoT-enabled Artificial Knee Joint Model for Objective Assessment in Orthopaedic Surgical Training

Ongoing

10

10

10

Scale-up and Benchmarking of Engineered β-Glucosidases to Develop Indigenous Enzyme Technology for Industrial Bioethanol Production

Scale-up and Benchmarking of Engineered β-Glucosidases to Develop Indigenous Enzyme Technology for Industrial Bioethanol Production

Scale-up and Benchmarking of Engineered β-Glucosidases to Develop Indigenous Enzyme Technology for Industrial Bioethanol Production

Ongoing

↑